These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23108868)

  • 1. The role and clinical implications of microRNAs in hepatocellular carcinoma.
    Zhao X; Yang Z; Li G; Li D; Zhao Y; Wu Y; Robson SC; He L; Xu Y; Miao R; Zhao H
    Sci China Life Sci; 2012 Oct; 55(10):906-19. PubMed ID: 23108868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma.
    Borel F; Konstantinova P; Jansen PL
    J Hepatol; 2012 Jun; 56(6):1371-83. PubMed ID: 22314424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma.
    Law PT; Wong N
    J Gastroenterol Hepatol; 2011 Mar; 26(3):437-49. PubMed ID: 21332540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?
    Giordano S; Columbano A
    Hepatology; 2013 Feb; 57(2):840-7. PubMed ID: 23081718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
    Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
    Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
    J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis.
    Huang YS; Dai Y; Yu XF; Bao SY; Yin YB; Tang M; Hu CX
    J Gastroenterol Hepatol; 2008 Jan; 23(1):87-94. PubMed ID: 18171346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
    Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
    Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
    Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
    Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [miRNAs in cancer: the case of liver tumors].
    Ladeiro Y; Zucman-Rossi J
    Med Sci (Paris); 2009 May; 25(5):467-72. PubMed ID: 19480827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and liver disease: viral hepatitis, liver fibrosis and hepatocellular carcinoma.
    Li G; Cai G; Li D; Yin W
    Postgrad Med J; 2014 Feb; 90(1060):106-12. PubMed ID: 24243965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
    Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
    Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
    Murakami Y; Yasuda T; Saigo K; Urashima T; Toyoda H; Okanoue T; Shimotohno K
    Oncogene; 2006 Apr; 25(17):2537-45. PubMed ID: 16331254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
    Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D
    Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA and hepatocellular carcinoma: biology and prognostic significance.
    Milazzo M; Fornari F; Gramantieri L
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):257-71. PubMed ID: 21769076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention?
    Wang Y; Lee CG
    Epigenomics; 2011 Apr; 3(2):235-43. PubMed ID: 22122284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early molecular and genetic determinants of primary liver malignancy.
    Feitelson MA; Pan J; Lian Z
    Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.